70 results
424B3
MRZM
Marizyme, Inc.
16 Nov 23
Prospectus supplement
6:08am
innovative solutions for coronary artery bypass, or CABG, surgery.
We are focused on commercializing or developing three medical technologies and related
8-K
EX-99.1
MRZM
Marizyme, Inc.
23 Oct 23
Marizyme CEO Delivers Business Update
9:15am
to the accelerated development and commercialization of innovative products that improve patient outcomes. Marizyme’s flagship product, DuraGraft™, has … by delivering innovative solutions for Coronary Artery Bypass Grafting surgery. DuraGraft™, with its CE Mark, continues to drive sales growth for the Company
424B3
MRZM
Marizyme, Inc.
17 Oct 23
Prospectus supplement
5:10pm
for widespread implementation of innovative fat grafting systems.
MAR-FG-001 is currently in development and not yet available for sale in any markets.
Our … Forward-Looking Statements”.
Overview
We are a medical technology company changing the landscape of cardiac care by delivering innovative solutions
8-K
o88fb
27 Dec 21
Marizyme Announces the Closing of My Health Logic
6:09am
8-K
mrmif
16 Nov 21
Marizyme Is Pleased to Announce the Appointment of David Barthel As Ceo
5:00pm
8-K
EX-99.1
k76byoc0jkdmsy
16 Nov 21
Marizyme Is Pleased to Announce the Appointment of David Barthel As Ceo
5:00pm
DEFR14A
3hf6u1
5 Aug 21
Revised proxy
9:40am
DEF 14A
ghq3tm8qwqj rg
23 Jun 21
Definitive proxy
4:15pm
PRE 14A
g5f3 zftgg84m
8 Jun 21
Preliminary proxy
4:05pm